Drug

Sugammadex

63 flagged reaction(s) · 2,498 total co-reports · max PRR 96.8

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Bronchospasm	174	96.8	103.5	signal
2	Anaphylactic Shock	173	53.5	57.1	signal
3	Anaphylactic Reaction	308	44.4	50.0	signal
4	Bradycardia	281	41.8	46.6	signal
5	Cardiac Arrest	188	17.9	19.2	signal
6	Ventricular Fibrillation	25	17.7	17.9	signal
7	Hypoxia	60	13.5	13.8	signal
8	Respiratory Arrest	47	13.3	13.5	signal
9	Muscle Twitching	39	13.3	13.5	signal
10	Oxygen Saturation Decreased	93	13.1	13.6	signal
11	Respiratory Depression	20	12.9	12.9	signal
12	Paralysis	23	12.6	12.7	signal
13	Tachypnoea	21	12.2	12.3	signal
14	Hypotonia	13	10.2	10.3	signal
15	Supraventricular Tachycardia	12	9.9	9.9	signal
16	Drug Reaction With Eosinophilia And Systemic Symptoms	32	9.9	10.0	signal
17	Serotonin Syndrome	21	8.6	8.7	signal
18	Angioedema	47	8.4	8.5	signal
19	Circulatory Collapse	18	8.3	8.3	signal
20	Ventricular Tachycardia	17	8.1	8.1	signal
21	Blood Pressure Decreased	67	8.0	8.1	signal
22	Obstructive Airways Disorder	11	7.8	7.8	signal
23	Hypertensive Crisis	11	7.8	7.8	signal
24	Cardiomyopathy	13	6.9	6.9	signal
25	Post Procedural Haemorrhage	10	6.7	6.8	signal
26	Eyelid Oedema	10	6.7	6.7	signal
27	Shock	19	6.6	6.6	signal
28	Cyanosis	13	6.5	6.5	signal
29	Hypotension	162	6.4	6.7	signal
30	Hypothermia	8	6.2	6.2	signal
31	Body Temperature Increased	16	6.2	6.2	signal
32	Muscle Rigidity	9	5.9	5.9	signal
33	Sinus Bradycardia	7	5.7	5.7	signal
34	Respiratory Distress	19	5.4	5.4	signal
35	Ventricular Extrasystoles	7	5.3	5.3	signal
36	Pulmonary Oedema	30	5.3	5.3	signal
37	Cardio-respiratory Arrest	28	5.2	5.3	signal
38	Pallor	18	5.2	5.2	signal
39	Respiratory Failure	48	5.2	5.3	signal
40	Tachycardia	58	5.1	5.2	signal
41	Product Prescribing Issue	13	5.0	5.0	signal
42	Maternal Exposure During Pregnancy	55	4.9	5.0	signal
43	Unresponsive To Stimuli	16	4.9	4.9	signal
44	Altered State Of Consciousness	13	4.7	4.8	signal
45	Heart Rate Decreased	20	4.5	4.5	signal
46	Dyskinesia	22	4.3	4.3	signal
47	Posterior Reversible Encephalopathy Syndrome	5	4.1	4.1	signal
48	Depressed Level Of Consciousness	20	4.0	4.0	signal
49	Drug Effect Incomplete	18	3.8	3.9	signal
50	Face Oedema	8	3.7	3.7	signal
51	Rash Maculo-papular	10	3.6	3.6	signal
52	Neuroleptic Malignant Syndrome	5	3.3	3.3	signal
53	Mydriasis	5	3.1	3.1	signal
54	Premature Delivery	5	2.5	2.5	no signal
55	Thrombotic Microangiopathy	3	2.4	2.4	no signal
56	Extra Dose Administered	11	2.2	2.2	signal
57	Circumstance Or Information Capable Of Leading To Medication Error	9	2.1	2.1	signal
58	Dystonia	5	2.0	2.0	no signal
59	Underdose	18	1.9	1.9	no signal
60	Injection Site Extravasation	3	1.9	1.9	no signal
61	No Adverse Event	40	1.8	1.8	no signal
62	Extrapyramidal Disorder	5	1.6	1.6	no signal
63	Foetal Exposure During Pregnancy	13	1.3	1.3	no signal